Axogen (AXGN) Liabilities and Shareholders Equity (2010 - 2026)
Axogen (AXGN) posted quarterly Liabilities and Shareholders Equity of $304.9 million for Q2 2026, up 48.39% year-over-year from $205.5 million in Q2 2025, and up 5.31% quarter-over-quarter from $289.5 million in Q1 2026.
Axogen (AXGN) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
Axogen's Liabilities and Shareholders Equity history runs 17 years deep, the most recent figure standing at $304.9 million for Q2 2026.
- In Q2 2026, Liabilities and Shareholders Equity rose 48.39% year-over-year to $304.9 million; the TTM figure through Jun 2026 stood at $1.0 billion (up 29.49% YoY), while the FY2025 annual figure was $221.7 million, up 8.82% from the prior year.
- Liabilities and Shareholders Equity for Q2 2026 stood at $304.9 million, up from $289.5 million in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $304.9 million in Q2 2026, with the low at $186.5 million in Q1 2024.
- The 5-year median for Liabilities and Shareholders Equity is $196.1 million (2022), against an average of $209.0 million.
- The sharpest annual moves came in 2022 and 2026: Liabilities and Shareholders Equity slipped 6.88% in 2022, then jumped 48.39% in 2026.
- Axogen's Liabilities and Shareholders Equity stood at $195.4 million in 2022, then rose by 0.74% to $196.8 million in 2023, then climbed by 3.51% to $203.7 million in 2024, then rose by 8.82% to $221.7 million in 2025, then jumped by 37.52% to $304.9 million in 2026.
- Business Quant data shows AXGN's Liabilities and Shareholders Equity at $304.9 million in Q2 2026, $289.5 million in Q1 2026, and $221.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 47.93 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 13.87 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 6.46 Bn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 37.25 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 31.04 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Axogen | 2.69 Bn | 2.58 Bn | 50.67 Mn | 304.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 304.86 Mn |
| Mar 31, 2026 | 289.49 Mn |
| Dec 31, 2025 | 221.69 Mn |
| Sep 30, 2025 | 216.40 Mn |
| Jun 30, 2025 | 205.45 Mn |
| Mar 31, 2025 | 196.17 Mn |
| Dec 31, 2024 | 203.73 Mn |
| Sep 30, 2024 | 191.99 Mn |
| Jun 30, 2024 | 188.93 Mn |
| Mar 31, 2024 | 186.52 Mn |
| Dec 31, 2023 | 196.83 Mn |
| Sep 30, 2023 | 194.63 Mn |
| Jun 30, 2023 | 191.64 Mn |
| Mar 31, 2023 | 189.47 Mn |
| Dec 31, 2022 | 195.39 Mn |
| Sep 30, 2022 | 195.52 Mn |
| Jun 30, 2022 | 196.08 Mn |
| Mar 31, 2022 | 198.03 Mn |
| Dec 31, 2021 | 208.02 Mn |
| Sep 30, 2021 | 209.97 Mn |